District Court Denies All Challenges To FDA Decision Concerning Rights To Market And Sell Generic Versions Of Pfizers Norvasc®

Mondaq Business Briefing › United States Law Articles in English (2007)

Author: Mr Philip Canelli

Author position: McDermott Will & Emery

Linked as:

< Previous

Next >

Extract

District Court Denies All Challenges To FDA Decision Concerning Rights To Market And Sell Generic Versions Of Pfizers Norvasc®

In a case involving generic versions of Pfizer's high blood pressure drug Norvasc® (amlodipine besylate) and the availability and applicability of both 180-day generic drug exclusivity and pediatric exc...

See the full content of this document

District Court Denies All Challenges To FDA Decision Concerning Rights To Market And Sell Generic Versions Of Pfizers Norvasc®

District Court Denies All Challenges To FDA Decision Concerning Rights To Market And Sell Generic Versions Of Pfizers Norvasc®